In Q1 (1 Apr–30 Jun 2026), net sales rose 6% to SEK 6,172m (from SEK 5,839m). Profitability improved with operating profit up 11% to SEK 870m (operating margin 14.1% vs 13.5%) and EBITA up 11% to SEK 1,026m (EBITA margin 16.6% vs 15.8%). Profit after tax increased 12% to SEK 631m (from SEK 562m), supporting a moderately positive earnings outlook.
The main signal is not the modest sales growth, but the fact that incremental revenue translated into outsized margin expansion. That usually comes from a better mix, pricing discipline, or a fixed-cost base that is still underutilized; in all three cases, the next leg of upside depends on whether the company can hold pricing once procurement and labor costs catch up.
For competitors, this is more important than it looks: if a mid-cap operator is expanding EBITA margins while growing mid-single digits, peers with weaker execution will have to choose between defending share and protecting profit. In the near term, that can pressure gross margins across the sub-sector, especially for smaller players with less purchasing leverage and lower automation. The second-order effect is that suppliers may see tougher annual renegotiations if this margin profile proves durable.
The risk is that the market extrapolates one clean quarter into a structural step-up. Over 1-3 months, the key catalyst is whether management raises full-year margin guidance or merely reiterates; without that, this is likely a quality signal, not a rerating event. Over 6-18 months, falsification would come from slower order intake, a step-up in wage/input inflation, or signs the margin gain was working-capital timing rather than true operating leverage.
Contrarian view: consensus may be underestimating how much of the improvement is self-help versus end-demand strength. If revenue growth is mostly price rather than volume, the earnings power is more fragile than the headline suggests. If volume acceleration shows up in the next print, the multiple can expand; if not, this is probably a hold rather than a buy.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialOverall Sentiment
moderately positive
Sentiment Score
0.35